HUE053084T2 - Streptococcus suis fertõzés elleni vakcinakészítmény - Google Patents

Streptococcus suis fertõzés elleni vakcinakészítmény

Info

Publication number
HUE053084T2
HUE053084T2 HUE15726586A HUE15726586A HUE053084T2 HU E053084 T2 HUE053084 T2 HU E053084T2 HU E15726586 A HUE15726586 A HU E15726586A HU E15726586 A HUE15726586 A HU E15726586A HU E053084 T2 HUE053084 T2 HU E053084T2
Authority
HU
Hungary
Prior art keywords
vaccine composition
streptococcus suis
composition against
against streptococcus
suis infection
Prior art date
Application number
HUE15726586A
Other languages
English (en)
Inventor
Jana Seele
Christoph Baums
Peter Valentin-Weigand
Original Assignee
Ceva Sante Animale S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50846835&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HUE053084(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ceva Sante Animale S A filed Critical Ceva Sante Animale S A
Publication of HUE053084T2 publication Critical patent/HUE053084T2/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria
    • C07K16/1275—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-positive bacteria from Streptococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A61K2039/575—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 humoral response

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
HUE15726586A 2014-05-30 2015-05-29 Streptococcus suis fertõzés elleni vakcinakészítmény HUE053084T2 (hu)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14170637.4A EP2949340A1 (en) 2014-05-30 2014-05-30 Vaccine composition against Streptococcus suis infection

Publications (1)

Publication Number Publication Date
HUE053084T2 true HUE053084T2 (hu) 2021-06-28

Family

ID=50846835

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE15726586A HUE053084T2 (hu) 2014-05-30 2015-05-29 Streptococcus suis fertõzés elleni vakcinakészítmény

Country Status (20)

Country Link
US (2) US20170209561A1 (hu)
EP (3) EP2949340A1 (hu)
JP (2) JP6670304B2 (hu)
KR (1) KR102480824B1 (hu)
CN (2) CN113769076A (hu)
AU (1) AU2015265884B2 (hu)
BR (1) BR112016028066A2 (hu)
CA (1) CA2947798A1 (hu)
DE (1) DE202015009979U1 (hu)
DK (1) DK3148576T3 (hu)
ES (1) ES2846698T3 (hu)
HU (1) HUE053084T2 (hu)
MX (1) MX2016015821A (hu)
MY (1) MY178365A (hu)
NZ (1) NZ726364A (hu)
PL (1) PL3148576T3 (hu)
PT (1) PT3148576T (hu)
RU (1) RU2735101C2 (hu)
WO (1) WO2015181356A1 (hu)
ZA (1) ZA201607627B (hu)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3319630A1 (en) 2015-07-09 2018-05-16 Intervacc AB Vaccine against s.suis infection
US20200038499A1 (en) * 2017-03-22 2020-02-06 Modernatx, Inc. Rna bacterial vaccines
BR112020002004A2 (pt) * 2017-08-03 2020-08-25 Intervet International B.V. vacina para proteção contra streptococcus suis
WO2019046691A1 (en) * 2017-08-31 2019-03-07 Merial, Inc. STREPTOCOCCUS AM VACCINES FOR THE PROTECTION AGAINST DISEASES OF REPRODUCTIVE PIGS, PIGLETS AND GROWING PIGS AND METHODS OF MAKING AND USING THEM
BR112020011831A2 (pt) * 2017-12-15 2020-11-24 Intervet International B.V. vacina para proteção contra streptococcus suis
CN111447945A (zh) * 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于保护以抗猪链球菌的疫苗
US20220339276A1 (en) * 2017-12-15 2022-10-27 Intervet Inc. A vaccine for protection against streptococcus suis
EP3549600A1 (en) 2018-04-03 2019-10-09 Intervet International B.V. A vaccine for protection against streptococcus suis
KR102073086B1 (ko) * 2018-06-04 2020-02-04 (주)인트론바이오테크놀로지 신규한 스트렙토코커스 수이스 박테리오파지 Str-SUP-1 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
CN112638409B (zh) 2018-08-27 2024-05-07 英特维特国际股份有限公司 组合疫苗
EP3876980A1 (en) * 2018-11-08 2021-09-15 Intervet International B.V. A vaccine for protection against streptococcus suis
US12023374B2 (en) 2018-11-23 2024-07-02 Intervet Inc. Vaccine for protection against Streptococcus suis
KR102524577B1 (ko) * 2019-04-22 2023-04-21 전남대학교산학협력단 플라젤린 융합 단백질 및 이의 용도
WO2021073778A1 (en) 2019-10-14 2021-04-22 Ceva Sante Animale Compositions and methods for vaccinating piglets against streptococcus
CN114728052A (zh) 2019-11-20 2022-07-08 英特维特国际股份有限公司 一种针对副猪嗜血杆菌的新型疫苗
CN114650840A (zh) 2019-11-20 2022-06-21 英特维特国际股份有限公司 一种针对副猪嗜血杆菌的新型疫苗
EP4061414A1 (en) 2019-11-20 2022-09-28 Intervet International B.V. A novel vaccine against heamophilus parasuis
JP2023517684A (ja) 2020-03-14 2023-04-26 インターベット インターナショナル ベー． フェー． ストレプトコッカス・スイス血清型９、配列型１６に対する防御のためのワクチン
CN112410310A (zh) * 2020-10-28 2021-02-26 天津农学院 一种猪链球菌疫苗重组蛋白gse及其制备方法和应用
CN113444694B (zh) * 2021-06-22 2022-09-30 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 马链球菌马亚种噬菌体sp2019-lx株及其在制备腺疫治疗性药物中的应用
CN117794565A (zh) 2021-08-03 2024-03-29 英特维特国际股份有限公司 用于保护以对抗多种血清型的猪链球菌的疫苗
EP4380612A1 (en) 2021-08-03 2024-06-12 Intervet International B.V. A vaccine for protection against streptococcus suis of various serotypes
WO2023011810A1 (en) 2021-08-03 2023-02-09 Intervet International B.V. A vaccine for protection against streptococcus suis of various serotypes
WO2023088988A1 (en) 2021-11-18 2023-05-25 Intervet International B.V. A method to produce a vaccine against streptococcus suis and the said vaccine
WO2023203238A1 (en) * 2022-04-22 2023-10-26 Intervacc Ab Streptococcus suis vaccine composition comprising immunogenic fusion polypeptides
WO2024112492A1 (en) * 2022-11-22 2024-05-30 Duke University Compositions comprising antibody cleaving enzymes and method of using the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA97452B (en) * 1996-01-25 1997-08-15 Trinity College Dublin Streptococcus equi vaccine.
OA11686A (en) * 1998-02-20 2005-01-12 Iaf Biochem Int Group B streptococcus antigens.
CN101124237A (zh) * 2001-04-13 2008-02-13 惠氏 酿脓链球菌的表面蛋白
DE10239629A1 (de) * 2002-08-23 2004-04-08 Idt Impfstoffwerk Dessau-Tornau Gmbh Nicht-rekombinate Subunit-Vakzine gegen Streptococcus suis-Infektionen des Schweines
CA2620774C (en) * 2005-09-02 2019-02-12 Universite De Montreal Streptococcus suis polypeptides and polynucleotides encoding same and their use in vaccinal and diagnostic applications
EP2227249B1 (en) * 2007-12-13 2018-04-25 Intervacc AB Improved immunizing composition
TW201043242A (en) * 2009-03-26 2010-12-16 Intervet Int Bv Vaccine for protection against Streptococcus suis bacteria of various serotypes
US9333252B2 (en) * 2010-05-26 2016-05-10 Intervacc Ab Vaccine against streptococcal infections based on recombinant proteins
BR112020011831A2 (pt) 2017-12-15 2020-11-24 Intervet International B.V. vacina para proteção contra streptococcus suis

Also Published As

Publication number Publication date
RU2016146801A3 (hu) 2018-12-10
CN106561082A (zh) 2017-04-12
ZA201607627B (en) 2020-09-30
RU2016146801A (ru) 2018-05-29
RU2735101C2 (ru) 2020-10-28
KR20170005855A (ko) 2017-01-16
US20210015910A1 (en) 2021-01-21
WO2015181356A1 (en) 2015-12-03
EP2949340A1 (en) 2015-12-02
DE202015009979U1 (de) 2022-05-23
AU2015265884B2 (en) 2021-03-04
ES2846698T3 (es) 2021-07-28
EP3795174A1 (en) 2021-03-24
MX2016015821A (es) 2017-04-25
EP3148576A1 (en) 2017-04-05
EP3148576B8 (en) 2020-12-30
NZ726364A (en) 2023-05-26
CN106561082B (zh) 2021-08-03
AU2015265884A1 (en) 2016-12-08
DK3148576T3 (da) 2021-01-18
CN113769076A (zh) 2021-12-10
WO2015181356A8 (en) 2016-12-22
PL3148576T3 (pl) 2021-05-04
JP2020019816A (ja) 2020-02-06
JP6909268B2 (ja) 2021-07-28
BR112016028066A2 (pt) 2017-10-24
JP2017518367A (ja) 2017-07-06
US20220401543A1 (en) 2022-12-22
PT3148576T (pt) 2021-02-01
EP3148576B1 (en) 2020-10-28
US20170209561A1 (en) 2017-07-27
MY178365A (en) 2020-10-09
KR102480824B1 (ko) 2022-12-22
JP6670304B2 (ja) 2020-03-18
CA2947798A1 (en) 2015-12-03

Similar Documents

Publication Publication Date Title
ZA201607627B (en) Vaccine composition against streptococcus suis infection
ZA201801035B (en) Vaccine compositions
GB201518684D0 (en) Vaccine
GB201410971D0 (en) Vaccine
IL247669A0 (en) 16-atom macrolide compound and their uses
PL3185899T3 (pl) Wzmocniona szczepionka wektorowa-hvt przeciwko nd-ibd
SG11201707926WA (en) Streptococcal vaccine
IL248223B (en) Compositions of vaccine
EP3131579A4 (en) Vaccine adjuvant compositions
GB201522132D0 (en) Vaccine
GB201616904D0 (en) Vaccine
EP3166957A4 (en) Sulfated-glycolipids as adjuvants for vaccines
GB201703529D0 (en) Vaccine composition
ZA201605935B (en) Topical antibiotic formulations
PT3188755T (pt) Vacina
PT3160263T (pt) Composições para prevenção de infeções
SG11201607464QA (en) Prophylactic agent for pneumococcal infection
GB201417214D0 (en) Vaccine
GB201521608D0 (en) Vaccine composition
GB201611084D0 (en) Vaccine compositions
AU2015901098A0 (en) Streptococcal vaccine
GB201603029D0 (en) Vaccine
AU2016902014A0 (en) Vaccine
GB201518917D0 (en) Vaccination
GB201503266D0 (en) Vaccination